GlassScriptPhysician profile
Angela Gonzalez
NPI 1861719981
$1,141.61
in general payments reported to CMS, 2019-2025
20 companies · $279 in 2025
The $279 reported for 2025 was more than what a typical Obstetrics & Gynecology provider received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $324 · 2020: $98.79 · 2021: $147 · 2022: $83.36 · 2023: $65.88 · 2024: $144 · 2025: $279.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $489.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $488.61 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Hologic Sales and Service, LLC | $207.54 | 2019-2025 | Fluent Fluid Management System, Myosure Tissue Removal Device |
| Duchesnay USA Incorporated | $170.54 | 2019 | |
| Mayne Pharma Commercial LLC | $132.26 | 2021-2024 | |
| Meditrina | $79.03 | 2021-2024 | |
| Optumhealth Care Solutions, LLC | $69.46 | 2025 | Eitan Medical, Vivify Health Care Team Portal 001 |
| Abbvie INC. | $67.21 | 2020-2023 | |
| Dysis Medical, INC. | $64.56 | 2020 | |
| Exeltis, USA INC. | $56.42 | 2019-2025 | Slynd |
| Coopersurgical, INC. | $54.88 | 2019-2024 | Paragard T 380a, Paragard T 380a |
| Pfizer INC. | $49.18 | 2022-2024 | |
| Baxter Healthcare | $26.68 | 2022 | |
| Therapeuticsmd, INC. | $24.63 | 2019-2021 | |
| Amag Pharmaceuticals, INC. | $23.68 | 2019 | |
| Gynesonics, INC. | $20.25 | 2024 | Sonata Sonography-Guided Transcervical Fibroid Ablation System |
| Astellas Pharma US INC | $19.26 | 2023 | Veozah |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $19.06 | 2025 | Proclaim |
| Merck Sharp & Dohme LLC | $17.54 | 2020 | |
| Bayer Healthcare Pharmaceuticals INC. | $16.14 | 2019 | |
| Mylan Pharmaceuticals INC. | $12.48 | 2019 | |
| Lupin INC. | $10.81 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Angela Gonzalez listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.